| Discrepancies between research advertisements and disclosure of study locations in trial registrations for USA-sponsored research in Russia. | |
| | |
MedLine Citation:
|
PMID: 20605999 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND AND AIM: The full disclosure of all locations at which research is conducted is an important requirement of clinical trial registration. Yet, little is known about how well researchers and sponsors disclose this information in their registrations. The aim of this study is to examine the adequacy of study location disclosure on http://ClinicalTrials.gov/ for recent USA-sponsored research in the Russian Federation. METHODS AND RESULTS: Information from advertisements for clinical research participation opportunities in Russia was compared with that in the corresponding trial registration in http://ClinicalTrials.gov/. Of 218 USA-sponsored trials advertised to Russian patients and physicians, nearly one-third did not disclose Russia as a study location in the registration. Longer trials were more likely to specify Russia as a study location. CONCLUSION: This study found that recent USA-sponsored clinical trials advertised to patients and physicians in the Russian Federation often do not specify Russia as a study location in their registrations on http://ClinicalTrials.gov/. The failure to fully disclose the locations at which research takes place undermines patients' ability to access information about potentially beneficial research opportunities, limits access to information, which may be important for identifying or avoiding ethically questionable practices, and may frustrate the ability to interpret the results of research. |
| | |
Authors:
|
D Patrone |
Related Documents
:
|
15908849 - Practical clinical trials for translating research to practice: design and measurement ... 20017899 - Statin research in critical illness: hampered by poor trial design? 11852169 - Streamlining irb review in multisite trials through single-study irb cooperative agreem... 12462959 - Going quasi: the premature disclosure effect in a randomized clinical trial. 21177629 - Ps1-30: o say can you c(er) - an inventory of comparative effectiveness research capaci... 20137069 - Association between framing of the research question using the picot format and reporti... 10727959 - The academic surgeon and industry. 6751099 - The dream of irma's injection: a structural analysis. 8304869 - Scleroderma. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of medical ethics Volume: 36 ISSN: 1473-4257 ISO Abbreviation: J Med Ethics Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7513619 Medline TA: J Med Ethics Country: England |
Other Details:
|
Languages: eng Pagination: 431-4 Citation Subset: E; IM |
Affiliation:
|
Philosophy Department, Union Graduate College-Mt Sinai School of Medicine Bioethics Program, Union College, 80 Nott Terrace, Schenectady, NY 13847, USA. dpatrone@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Research ethics in dissertations: ethical issues and complexity of reasoning.
Next Document: Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in ...